Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRIS-2: Ibodutant in IBS-D
NCT01303224Phase 2Completed
- Sponsor
- Menarini Group
- Start
- Oct 2010
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of ibodutant in Irritable bowel syndrome with diarrhea (IBS-D), sponsored by Menarini Group. Started Oct 2010; status: completed.
02
Drugs
ibodutant
03
Conditions
Irritable bowel syndrome with diarrhea (IBS-D)
Beyond the preview
Go deeper on NCT01303224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01303224.